Llama Nanoantibodies with Therapeutic Potential against Human Norovirus Diarrhea

• Lorena Garaicoechea,

  Affiliation Instituto de Virología, INTA, Castelar, Buenos Aires, Argentina

  ⨯
• Andrea Aguilar,

  Affiliation Instituto de Virología, INTA, Castelar, Buenos Aires, Argentina

  ⨯
• Gabriel I. Parra,

  Affiliation Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Marina Bok,

  Affiliation Instituto de Virología, INTA, Castelar, Buenos Aires, Argentina

  ⨯
• Stanislav V. Sosnovtsev,

  Affiliation Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Gabriela Canziani,

  Affiliation Instituto Leloir, Buenos Aires, Argentina

  ⨯
• Kim Y. Green,

  Affiliation Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Karin Bok,

  Affiliation Laboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, Maryland, United States of America

  ⨯
• Viviana Parreño

  * E-mail: parreno.viviana@inta.gob.ar

  Affiliation Instituto de Virología, INTA, Castelar, Buenos Aires, Argentina

  ⨯